267 related articles for article (PubMed ID: 9609124)
1. Insulin action in skeletal muscle from patients with NIDDM.
Zierath JR; Krook A; Wallberg-Henriksson H
Mol Cell Biochem; 1998 May; 182(1-2):153-60. PubMed ID: 9609124
[TBL] [Abstract][Full Text] [Related]
2. Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance.
Zierath JR; Galuska D; Nolte LA; Thörne A; Kristensen JS; Wallberg-Henriksson H
Diabetologia; 1994 Mar; 37(3):270-7. PubMed ID: 8174841
[TBL] [Abstract][Full Text] [Related]
3. Insulin action on glucose transport and plasma membrane GLUT4 content in skeletal muscle from patients with NIDDM.
Zierath JR; He L; Gumà A; Odegoard Wahlström E; Klip A; Wallberg-Henriksson H
Diabetologia; 1996 Oct; 39(10):1180-9. PubMed ID: 8897005
[TBL] [Abstract][Full Text] [Related]
4. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation.
Björnholm M; Kawano Y; Lehtihet M; Zierath JR
Diabetes; 1997 Mar; 46(3):524-7. PubMed ID: 9032113
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of improving effect of losartan on insulin sensitivity of non-insulin-dependent diabetes mellitus rats.
Wu Y; Ouyang JP; Zhou YF; Wu K; Zhao DH; Wen CY
Sheng Li Xue Bao; 2004 Aug; 56(4):539-49. PubMed ID: 15322693
[TBL] [Abstract][Full Text] [Related]
6. Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM.
Bonadonna RC; Del Prato S; Bonora E; Saccomani MP; Gulli G; Natali A; Frascerra S; Pecori N; Ferrannini E; Bier D; Cobelli C; DeFronzo RA
Diabetes; 1996 Jul; 45(7):915-25. PubMed ID: 8666143
[TBL] [Abstract][Full Text] [Related]
7. Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects.
Ciaraldi TP; Abrams L; Nikoulina S; Mudaliar S; Henry RR
J Clin Invest; 1995 Dec; 96(6):2820-7. PubMed ID: 8675652
[TBL] [Abstract][Full Text] [Related]
8. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
[TBL] [Abstract][Full Text] [Related]
9. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures.
Henry RR; Abrams L; Nikoulina S; Ciaraldi TP
Diabetes; 1995 Aug; 44(8):936-46. PubMed ID: 7622000
[TBL] [Abstract][Full Text] [Related]
10. Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM.
Simoneau JA; Kelley DE
J Appl Physiol (1985); 1997 Jul; 83(1):166-71. PubMed ID: 9216960
[TBL] [Abstract][Full Text] [Related]
11. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects.
Krook A; Roth RA; Jiang XJ; Zierath JR; Wallberg-Henriksson H
Diabetes; 1998 Aug; 47(8):1281-6. PubMed ID: 9703329
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
13. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
Vestergaard H
Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
[TBL] [Abstract][Full Text] [Related]
14. Sulfonylurea therapy improves glucose disposal without changing skeletal muscle GLUT4 levels in noninsulin-dependent diabetes mellitus subjects: a longitudinal study.
Vestergaard H; Weinreb JE; Rosen AS; Bjørbaek C; Hansen L; Pedersen O; Kahn BB
J Clin Endocrinol Metab; 1995 Jan; 80(1):270-5. PubMed ID: 7829624
[TBL] [Abstract][Full Text] [Related]
15. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
[TBL] [Abstract][Full Text] [Related]
16. Sending the signal: molecular mechanisms regulating glucose uptake.
Krook A; Wallberg-Henriksson H; Zierath JR
Med Sci Sports Exerc; 2004 Jul; 36(7):1212-7. PubMed ID: 15235328
[TBL] [Abstract][Full Text] [Related]
17. Insulin signaling and glucose transport in insulin resistant skeletal muscle. Special reference to GLUT4 transgenic and GLUT4 knockout mice.
Galuska D; Ryder J; Kawano Y; Charron MJ; Zierath JR
Adv Exp Med Biol; 1998; 441():73-85. PubMed ID: 9781315
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms.
Henry RR; Ciaraldi TP; Abrams-Carter L; Mudaliar S; Park KS; Nikoulina SE
J Clin Invest; 1996 Sep; 98(5):1231-6. PubMed ID: 8787686
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM.
Utriainen T; Takala T; Luotolahti M; Rönnemaa T; Laine H; Ruotsalainen U; Haaparanta M; Nuutila P; Yki-Järvinen H
Diabetologia; 1998 May; 41(5):555-9. PubMed ID: 9628273
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus.
Petersen KF; Shulman GI
Am J Cardiol; 2002 Sep; 90(5A):11G-18G. PubMed ID: 12231074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
